Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility

Molecular Biology Reports

Volumn 38, Issue 7, 2011, Pages 4491-4494

  Qiu, Li Xin ^a,b   Wang, Ke ^c   Yang, Sheng ^d   Mao, Chen ^e   Zhao, Lei ^f   Yao, Lei ^g   Zhang, Jian ^a,b   Zhang, Qun Ling ^a,b   Sun, Si ^a,b   Xue, Kai ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

^d FUJIAN MEDICAL UNIVERSITY   (China)

^e SOUTHERN MEDICAL UNIVERSITY   (China)

^f WUHAN UNIVERSITY   (China)

^g FUDAN UNIVERSITY   (China)

Author keywords

Breast cancer; Polymorphism; Susceptibility; VEGF

Indexed keywords

VASCULOTROPIN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; SYSTEMATIC REVIEW;

BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79958208279     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0579-z     Document Type: Article

References (27)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics 2002 CA Cancer J Clin 55 74 108 15761078 10.3322/canjclin.55.2.74
2. P Lichtenstein NV Holm PK Verkasalo 2000 Environmental and heritable factors in the causation of cancer N Engl J Med 343 78 85 10891514 10.1056/NEJM200007133430201 1:STN:280:DC%2BD3czjtFCiug%3D%3D
3. N Ferrara 2002 VEGF and the quest for tumour angiogenesis factors Nat Rev Cancer 2 795 803 12360282 10.1038/nrc909 1:CAS:528:DC%2BD38XnsVGrtbk%3D
4. YS Chae JG Kim SK Sohn 2006 Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer Oncology 71 e72 e78 10.1159/000106788
5. K Dassoulas M Gazouli S Rizos G Theodoropoulos Z Christoni 2009 Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival Mol Carcinog 48 e9 e15 10.1002/mc.20495
6. W Renner S Kotschan C Hoffmann 2000 A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels J Vasc Res 37 443 448 11146397 10.1159/000054076 1:CAS:528:DC%2BD3MXoslGmsQ%3D%3D
7. A Jakubowska K Jaworska C Cybulski 2009 Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer 45 837 842 19071013 10.1016/j.ejca.2008.10.021 1:CAS:528:DC%2BD1MXisl2rsLY%3D
8. GT Lin HF Tseng CH Yang 2009 Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan OMICS 13 165 173 19196101 10.1089/omi.2008.0050 1:CAS:528:DC%2BD1MXkt1ChtbY%3D
9. SP Balasubramanian A Cox SS Cross 2007 Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity Int J Cancer 121 1009 1016 17471570 10.1002/ijc.22772 1:CAS:528:DC%2BD2sXhtFGhu7vP
10. N Kataoka Q Cai W Wen 2006 Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women Cancer Epidemiol Biomarkers Prev 15 1148 1152 16775174 10.1158/1055-9965.EPI-05-0871 1:CAS:528:DC%2BD28Xls1ehsbo%3D
11. EJ Jacobs HS Feigelson EB Bain 2006 Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the cancer prevention study II cohort Breast Cancer Res 8 R22 R27 16613616 10.1186/bcr1400
12. Q Jin K Hemminki K Enquist 2005 Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis Clin Cancer Res 11 3647 3653 15897560 10.1158/1078-0432.CCR-04-1803 1:CAS:528: DC%2BD2MXktFyrsbs%3D
13. P Krippl U Langsenlehner W Renner 2003 A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk Int J Cancer 106 468 471 12845639 10.1002/ijc.11238 1:CAS:528:DC%2BD3sXmtlyqu7Y%3D
14. PD Pharoah J Tyrer AM Dunning DF Easton BAJ Ponder 2007 Association between common variation in 120 candidate genes and breast cancer risk PLoS Genet 3 e42 e47 17367212 10.1371/journal.pgen.0030042
15. WG Cochran 1954 The combination of estimates from different experiments Biometrics 10 101 129 10.2307/3001666
16. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748 13655060 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D
17. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188 3802833 10.1016/0197-2456(86)90046-2 1:STN:280: DyaL2s7gsVamtA%3D%3D
18. A Tobias 1999 Assessing the influence of a single study in the meta-analysis estimate Stata Tech Bull 8 15 17
19. M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 629 634 9310563 1:STN:280:DyaK2svls1KjtA%3D%3D
20. P Carmeliet RK Jain 2000 Angiogenesis in cancer and other diseases Nature 407 e57 e63 10.1038/35025220
21. N Ferrara 2004 Vascular endothelial growth factor: basic science and clinical progress Endocr Rev 25 581 611 15294883 10.1210/er.2003-0027 1:CAS:528:DC%2BD2cXns1Ght74%3D
22. JN Hirschhorn K Lohmueller E Byrne 2002 A comprehensive review of genetic association studies Genet Med 4 45 61 11882781 10.1097/00125817-200203000-00002 1:CAS:528:DC%2BD38XjtFSru7w%3D
23. LX Qiu J Zhang XD Zhu CL Zheng S Sun ZH Wang 2010 The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51, 236 subjects Breast Cancer Res Treat 124 475 479 20349127 10.1007/s10549-010-0858-3 1:CAS:528:DC%2BC3cXht12qurzI
24. LX Qiu L Yao J Zhang XD Zhu XM Zhao K Xue 2010 XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28, 709 subjects Breast Cancer Res Treat 124 229 235 20204500 10.1007/s10549-010-0813-3 1:CAS:528:DC%2BC3cXht1elsLjN
25. LX Qiu L Yao C Mao B Chen P Zhan K Xue 2010 TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47, 817 subjects Breast Cancer Res Treat 123 563 567 20143152 10.1007/s10549-010-0781-7 1:CAS:528:DC%2BC3cXpvFegtb8%3D
26. LX Qiu L Yao K Xue J Zhang C Mao B Chen 2010 BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44, 903 subjects Breast Cancer Res Treat 123 487 490 20135345 10.1007/s10549-010-0767-5 1:CAS:528:DC%2BC3cXpvFegur8%3D
27. LX Qiu H Yuan KD Yu 2010 Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46, 281 subjects Breast Cancer Res Treat 121 703 708 19936916 10.1007/s10549-009-0636-2 1:CAS:528:DC%2BC3cXmtVyrsb0%3D